New nerve block could cut opioid use after heart surgery

NCT ID NCT07420712

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a nerve block called the serratus posterior superior intercostal plane block can reduce pain and the need for strong painkillers after minimally invasive heart surgery. Sixty adults will be randomly assigned to receive either the nerve block plus standard pain management or standard pain management alone. Researchers will measure opioid use, pain scores, and recovery times to see if the block improves outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Bupivacaine
What this could lead to
If successful, this nerve block could become a standard way to manage pain after heart surgery, reducing the need for strong painkillers and speeding recovery.
What could go wrong
This is a small, early-stage study (60 people) testing a specific procedure. Results may not apply to all patients or surgeries, and the block may not provide significant pain relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANALGESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kosuyolu High Specialization Training and Research Hospital

    RECRUITING

    Istanbul, 34870, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.